Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nathan Wlodarchak & Yongna Xing. (2016) PP2A as a master regulator of the cell cycle. Critical Reviews in Biochemistry and Molecular Biology 51:3, pages 162-184.
Read now
Read now
Shuo Qie & Nianli Sang. (2011)
Release the ink4a/arf growth suppression by “u” and “me”?
. Cell Cycle 10:2, pages 185-190.
Read now
Read now
Belinda J. Westman & Angus I. Lamond. (2011)
A role for SUMOylation in snoRNP biogenesis revealed by quantitative proteomics
. Nucleus 2:1, pages 30-37.
Read now
Read now
Articles from other publishers (29)
Changming Dong, Pengyu Hui, Liang Zheng & Yanping Huang. (2023) Primary adrenocortical carcinoma with mutation in CDKN2A gene. Asian Journal of Surgery.
Crossref
Crossref
Guanlin Wu, Weiming Guo, Shuai Zhu & Gang Fan. (2023) Single-Cell and Transcriptome-Based Immune Cell-Related Prognostic Model in Clear Cell Renal Cell Carcinoma. Journal of Oncology 2023, pages 1-15.
Crossref
Crossref
Abir Zebian, Maya El-Dor, Abdullah Shaito, Frédéric Mazurier, Hamid Reza Rezvani & Kazem Zibara. (2022) XPC multifaceted roles beyond DNA damage repair: p53-dependent and p53-independent functions of XPC in cell fate decisions. Mutation Research/Reviews in Mutation Research 789, pages 108400.
Crossref
Crossref
Gareth W. Fearnley, Antony M. Latham, Monica Hollstein, Adam F. Odell & Sreenivasan Ponnambalam. (2020) ATF-2 and Tpl2 regulation of endothelial cell cycle progression and apoptosis. Cellular Signalling 66, pages 109481.
Crossref
Crossref
Zhi Yang, Shuai Jiang, Chenxi Lu, Ting Ji, Wenwen Yang, Tian Li, Jianjun Lv, Wei Hu, Yang Yang & Zhenxiao Jin. (2019) SOX11: friend or foe in tumor prevention and carcinogenesis?. Therapeutic Advances in Medical Oncology 11, pages 175883591985344.
Crossref
Crossref
Sofia S Pereira, Mariana P Monteiro, Isabelle Bourdeau, André Lacroix & Duarte Pignatelli. (2018) MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma. European Journal of Endocrinology 179:2, pages R95-R110.
Crossref
Crossref
R. Hou, X. Kong, B. Yang, Y. Xie & G. Chen. (2017) SLC14A1: a novel target for human urothelial cancer. Clinical and Translational Oncology 19:12, pages 1438-1446.
Crossref
Crossref
César Muñoz-Fontela, Anna Mandinova, Stuart A. Aaronson & Sam W. Lee. (2016) Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nature Reviews Immunology 16:12, pages 741-750.
Crossref
Crossref
Matthew J. Cecchini, Charles A. Ishak, Daniel T. Passos, Andrew Warner, David A. Palma, Christopher J. Howlett, David K. Driman & Frederick A. Dick. (2015) Loss of the retinoblastoma tumor suppressor correlates with improved outcome in patients with lung adenocarcinoma treated with surgery and chemotherapy. Human Pathology 46:12, pages 1922-1934.
Crossref
Crossref
Alper Yetil, Benedict Anchang, Arvin M. Gouw, Stacey J. Adam, Tahera Zabuawala, Ramya Parameswaran, Jan van Riggelen, Sylvia Plevritis & Dean W. Felsher. (2015) p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia. Oncotarget 6:6, pages 3563-3577.
Crossref
Crossref
Christine M. Lusk, Greg Dyson, Andrew G. Clark, Christie M. Ballantyne, Ruth Frikke-Schmidt, Anne Tybjærg-Hansen, Eric Boerwinkle & Charles F. Sing. (2014) Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study. Human Genetics 133:9, pages 1105-1116.
Crossref
Crossref
Minyoung Lee & Jae-Seon Lee. (2014) Exploiting tumor cell senescence in anticancer therapy. BMB Reports 47:2, pages 51-59.
Crossref
Crossref
M Z Lin, K A Marzec, J L Martin & R C Baxter. (2012) The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. Oncogene 33:1, pages 85-96.
Crossref
Crossref
Yaara Levav-Cohen, Zehavit Goldberg, Kah Hin Tan, Osnat Alsheich-Bartok, Valentina Zuckerman, Sue Haupt & Ygal Haupt. 2014. Mutant p53 and MDM2 in Cancer. Mutant p53 and MDM2 in Cancer
161
186
.
Emmanuel Martinez & Victor Trevino. (2013) Modelling gene expression profiles related to prostate tumor progression using binary states. Theoretical Biology and Medical Modelling 10:1.
Crossref
Crossref
Maria Cristina De Martino, Abir Al Ghuzlan, Sebastien Aubert, Guillaume Assié, Jean-Yves Scoazec, Sophie Leboulleux, Christine Do Cao, Rossella Libè, Cécile Nozières, Marc Lombès, François Pattou, Francoise Borson-Chazot, Ségolène Hescot, Clement Mazoyer, Jacques Young, Isabelle Borget, Annamaria Colao, Rosario Pivonello, Jean-Charles Soria, Jerome Bertherat, Martin Schlumberger, Ludovic Lacroix & Eric Baudin. (2013) Molecular Screening for a Personalized Treatment Approach in Advanced Adrenocortical Cancer. The Journal of Clinical Endocrinology & Metabolism 98:10, pages 4080-4088.
Crossref
Crossref
Kayo Yamada, Motoharu Ono, Neil D. Perkins, Sonia Rocha & Angus I. Lamond. (2013) Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21. Molecular Cell 49:5, pages 922-933.
Crossref
Crossref
K.M. Hannan, E. Sanij, L.I. Rothblum, R.D. Hannan & R.B. Pearson. (2013) Dysregulation of RNA polymerase I transcription during disease. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1829:3-4, pages 342-360.
Crossref
Crossref
Qin ZhangErick SpearsDavid N. Boone, Zhaoliang LiMark A. Gregory & Stephen R. Hann. (2012) Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proceedings of the National Academy of Sciences 110:3, pages 978-983.
Crossref
Crossref
Inken Wierstra. 2013.
191
419
.
Pierre Hainaut. 2013. p53 in the Clinics. p53 in the Clinics
1
23
.
George K. Acquaah-Mensah, Deepti Malhotra, Madhulika Vulimiri, Jason E. McDermott & Shyam Biswal. (2012) Suppressed Expression of T-Box Transcription Factors Is Involved in Senescence in Chronic Obstructive Pulmonary Disease. PLoS Computational Biology 8:7, pages e1002597.
Crossref
Crossref
Anna Travesa, Dwight Kuo, Robertus A M de Bruin, Tatyana I Kalashnikova, Marisela Guaderrama, Kevin Thai, Aaron Aslanian, Marcus B Smolka, John R YatesIIIIII, Trey Ideker & Curt Wittenberg. (2012) DNA replication stress differentially regulates G1/S genes via Rad53-dependent inactivation of Nrm1. The EMBO Journal 31:7, pages 1811-1822.
Crossref
Crossref
Jongkyu Choi, Hyunjung Kim, Kyunghwan Kim, Bomi Lee, Wange Lu & Woojin An. (2011) Selective requirement of H2B N-Terminal tail for p14ARF-induced chromatin silencing. Nucleic Acids Research 39:21, pages 9167-9180.
Crossref
Crossref
Hansong Du, Weiqi Yao, Min Fang & Dongcheng Wu. (2011) ARF triggers cell G1 arrest by a P53 independent ERK pathway. Molecular and Cellular Biochemistry 357:1-2, pages 415-422.
Crossref
Crossref
Jackson R. Taylor, Brian D. Lehmann, William H. Chappell, Stephen L. Abrams, Linda S. Steelman & James A. McCubrey. (2011) Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells. Oncotarget 2:8, pages 610-626.
Crossref
Crossref
Moriko Ito, Louise Barys, Terence O'Reilly, Sophie Young, Bella Gorbatcheva, John Monahan, Sabine Zumstein-Mecker, Peter F. Choong, Ian Dickinson, Philip Crowe, Christine Hemmings, Jayesh Desai, David M. Thomas & Joanna Lisztwan. (2011)
Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and
MDM2
Amplification in Sarcomagenesis
. Clinical Cancer Research 17:3, pages 416-426.
Crossref
Crossref
Pankaj Taneja, Sinan Zhu, Dejan Maglic, Eizabeth A. Fry, Robert D. Kendig & Kazushi Inoue. (2011) Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes. Clinical Medicine Insights: Oncology 5, pages CMO.S7516.
Crossref
Crossref
Elin Gustavsson, Sandra Sernbo, Elin Andersson, Donal J. Brennan, Michael Dictor, Mats Jerkeman, Carl A. K. Borrebaeck & Sara Ek. (2010) SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Molecular Cancer 9:1.
Crossref
Crossref